Back to results
US 2022/0033849 A1Published application
Methods for the purification of viral vectors
AssigneesBioverativ Therapeutics Inc., Fondazione Telethon, Ospedale San Raffaele S.R.L.
InventorsMukesh Mayani, Tongyao Liu, Ayman Ismail
Life of this patent
Estimating the term…
Abstract
Viral vector production processes and methods of purifying a viral vector from a host cell are provided herein.
Claims28
A method of purifying a viral vector from a host cell, the method comprising:
- (i) contacting a composition comprising the viral vector and a transgene protein contaminant with a first chromatography matrix capable of selectively binding the transgene protein contaminant;
- and
- (ii) recovering the viral vector in the flow-through of the chromatography matrix,
- thereby separating the viral vector from the transgene protein contaminant.
1 more element
(canceled)
-13. (canceled)
(canceled)
-25. (canceled)
-28. (canceled)
-35. (canceled)
A method of purifying a lentiviral vector (LVV) from a host cell, the LVV comprising a factor VIII (FVIII) transgene, the method comprising:
- (i) contacting a composition comprising the LVV and a FVIII transgene protein contaminant with a first chromatography matrix capable of selectively binding FVIII transgene protein contaminant;
- and
- (ii) recovering the LVV in the flow-through of the chromatography matrix,
- thereby separating the LVV from the FVIII protein contaminant.
1 more element
-65. (canceled)
-74. (canceled)
Dependencies are inferred from the claim text.